Cladribine

In the US, Cladribine (cladribine systemic) is a member of the drug class antimetabolites and is used to treat Hairy Cell Leukemia and Multiple Sclerosis.

US matches:

• Cladribine


• Cladribine Novaplus


• Cladribine Intravenous

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

L01BB04

CAS registry number (Chemical Abstracts Service)

0004291-63-8

Chemical Formula

C10-H12-Cl-N5-O3

Molecular Weight

285

Therapeutic Category

Antineoplastic agent, antimetabolite

Chemical Name

2-Chloro-2'-deoxyadenosine

Foreign Names

• Cladribinum (Latin)
• Cladribin (German)
• Cladribine (French)
• Cladribina (Spanish)

Generic Names

• Cladribine (OS: BAN, DCF, USAN)
• CdA (IS)
• Chlorodeoxyadenosine (IS)
• RWJ 26251 (IS)
• RWJ 26251-000 (IS)
• Cladribine (PH: USP 32, Ph. Eur. 6, BP 2010)
• Cladribinum (PH: Ph. Eur. 6)

Brand Names

• Biodribin
  Inst. Biotechn. i Antybiotykow, Poland



• Cladribine for Injection
  APP, United States; Bedford, United States



• Intocel
  Sidus, Argentina



• Leustat
  Janssen, Argentina; Janssen, Saudi Arabia; Janssen-Cilag, United Arab Emirates; Janssen-Cilag, Bahrain; Janssen-Cilag, Egypt; Janssen-Cilag, United Kingdom; Janssen-Cilag, Iraq; Janssen-Cilag, Iran; Janssen-Cilag, Jordan; Janssen-Cilag, Kuwait; Janssen-Cilag, Lebanon; Janssen-Cilag, Oman; Janssen-Cilag, Qatar; Janssen-Cilag, Syria; Janssen-Cilag, Yemen



• Leustatin
  Janssen, Australia; Janssen, Belgium; Janssen, Brazil; Janssen, Costa Rica; Janssen, Czech Republic; Janssen, Germany; Janssen, Dominican Republic; Janssen, Spain; Janssen, Finland; Janssen, Greece; Janssen, Guatemala; Janssen, Hong Kong; Janssen, Honduras; Janssen, Israel; Janssen, Iceland; Janssen, Italy; Janssen, Luxembourg; Janssen, Nicaragua; Janssen, Netherlands; Janssen, Norway; Janssen, New Zealand; Janssen, Panama; Janssen, Philippines; Janssen, El Salvador; Janssen, Taiwan; Janssen Pharmaceutical K.K., Japan; Janssen-Cilag, Austria; Janssen-Cilag, Switzerland; Janssen-Cilag, Denmark; Janssen-Cilag, Sweden; Janssen-Cilag, South Africa; Janssen-Ortho Inc., Canada; Johnson & Johnson, Slovakia; Ortho Biotech, United States



• Leustatine
  Janssen-Cilag, France



• Litak
  Haupt, Romania; Key Oncologics, South Africa; Lipomed, Austria; Lipomed, Switzerland; Lipomed, Czech Republic; Lipomed, Germany; Lipomed, Denmark; Lipomed, Spain; Lipomed, France; Lipomed, Israel; Lipomed, Serbia; Lipomed, Slovenia; Lipomed, Slovakia; Medifront, Finland; Medis Adria, Croatia (Hrvatska); Orphan, Australia; ZLB Behring, Luxembourg

International Drug Name Search

Glossary

BAN	British Approved Name
DCF	Dénomination Commune Française
IS	Inofficial Synonym
OS	Official Synonym
PH	Pharmacopoeia Name
Rec.INN	Recommended International Nonproprietary Name (World Health Organization)
USAN	United States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.